Gainers

  • DAVIDsTEA Inc.DTEA rose 50.7 percent to $5.05 in pre-market trading after gaining 11.67 percent on Thursday.
  • New Age Beverages Corporation NBEVshares rose 26.8 percent to $9.95 in pre-market trading after climbing 79.63 percent on Thursday.
  • Oasmia Pharmaceutical AB OASMshares rose 24.2 percent to $3.18 in pre-market trading after dropping 6.91 percent on Thursday.
  • India Globalization Capital, Inc.IGC rose 18.6 percent to $2.55 in pre-market trading after surging 27.22 percent on Thursday.
  • Therapix Biosciences Ltd.TRPX rose 17.2 percent to $6.70 in pre-market trading after surging 34.91 percent on Thursday.
  • Steelcase Inc.SCS rose 14.6 percent to $18.50 in pre-market trading after the company reported better-than-expected earnings for its second quarter. The company issued strong Q3 and FY19 earnings guidance.
  • Agenus Inc.AGEN shares rose 11.4 percent to $2.34 in pre-market trading. XOMA reported the purchase of royalty interest position from Agenus on 7 assets being developed by Merck and Incyte for $15 million.
  • Mazor Robotics Ltd.MZOR rose 9.6 percent to $57.80 in pre-market trading after Medtronic PLC MDT announced plans to acquire Mazor Robotics for $58.50 per ADS in cash.
  • Cool Holdings, Inc.AWSM shares rose 9.5 percent to $11.50 in pre-market after surging 53.28 percent on Thursday.
  • Energy XXI Gulf Coast, Inc.EGC rose 7.3 percent to $6.63 in pre-market trading after issuing statement related to merger with affiliates of Cox Oil.
  • Opiant Pharmaceuticals IncOPNT rose 7.2 percent to $24.00 in pre-market trading after the company reported a $4.6-million contract to accelerate development of OPNT003 for the treatment of opioid overdoses.
  • China Southern Airlines Company Limited ZNHrose 7.2 percent to $35.00.
  • DBV Technologies S.A.DBVT shares rose 5.8 percent to $25.57 in pre-market trading.
  • NIO Inc.NIO rose 5 percent to $9.22 in pre-market trading after gaining 3.29 percent on Thursday.

 

Losers

  • Titan Pharmaceuticals, Inc.TTNP fell 55 percent to $0.22 in pre-market trading after the company priced its $9.5 million public offering.
  • Avino Silver & Gold Mines LtdASM shares fell 26.4 percent to $0.58 in pre-market after reporting a common stock offering.
  • Pier 1 Imports Inc PIRshares fell 17.2 percent to $1.50 in pre-market trading after reporting weak preliminary earnings results for its second quarter. The company expects Q2 loss of $0.64 to $0.62 per share and comparable sales to drop around 11.4 percent year-over-year.
  • Ur-Energy Inc.URG shares fell 13.7 percent to $0.80 in pre-market trading after reporting a common stock offering.
  • Altimmune, Inc. ALTfell 12.7 percent to $22.91 in pre-market trading after climbing 59.36 percent on Thursday.
  • MiMedx Group, Inc.MDXG shares fell 11.3 percent to $5.50 in pre-market trading. MiMedx reported Nasdaq listing extension through February 25.
  • United Natural Foods, Inc.UNFI fell 10.6 percent to $30.25 in pre-market trading after the company reported weaker-than-expected results for its fourth quarter.
  • Mechel PAO MTLfell 6.2 percent to $3.21 in pre-market trading after rising 17.12 percent on Thursday.
  • Micron Technology, Inc.MU fell 5.8 percent to $43.38 in pre-market trading. Micron reported upbeat earnings for its fourth quarter, but issued weak guidance for its current quarter.
  • Tilray, Inc.TLRY shares fell 5.8 percent to $166.11 in pre-market trading after dropping 17.62 percent on Thursday.
  • Western Asset Mortgage Capital Corporation WMCfell 5.5 percent to $10.69 in pre-market trading after reporting a 6.5 million share common stock offering.
  • Sociedad Química y Minera de Chile S.A.SQM shares fell 5.3 percent to $45.85 in pre-market trading.
  • SMART Global Holdings, Inc.SGH fell 4.8 percent to $29.00 in pre-market trading after rising 2.28 percent on Thursday.
  • Tata Motors Limited TTMfell 4.7 percent to $17 in pre-market trading.
  • Fate Therapeutics IncFATE fell 4.5 percent to $13.40 in pre-market trading. Fate Therapeutics priced its 9.2 million share public offering of common stock at $13.50 per share.
  • Crispr Therapeutics AGCRSP fell 3.6 percent to $47.23 in the pre-market trading session. CRISPR Therapeutics priced its 4.2 million share offering at $47.50 per share.